These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6751010)

  • 41. The postural plasma renin activity response in essential hypertension and primary hyperaldosteronism.
    Nielsen I; Moller I
    Acta Med Scand; 1969 Oct; 186(4):265-72. PubMed ID: 4907778
    [No Abstract]   [Full Text] [Related]  

  • 42. Long term evolution of glucocorticoid-suppressible hyperaldosteronism.
    Stockigt JR; Scoggins BA
    J Clin Endocrinol Metab; 1987 Jan; 64(1):22-6. PubMed ID: 3536983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysis.
    Takeda R; Morimoto S; Uchida K; Miyamori I
    Acta Endocrinol (Copenh); 1976 Aug; 82(4):715-27. PubMed ID: 947281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinical utility of two renin mass methods to detect primary hyperaldosteronism compared with renin activity.
    Wedatilake YN; Scanlon MJ; Barnes SC
    Ann Clin Biochem; 2011 May; 48(Pt 3):256-62. PubMed ID: 21427267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased adrenal sensitivity to angiotensin II in idiopathic hyperaldosteronism.
    Wisgerhof M; Carpenter PC; Brown RD
    J Clin Endocrinol Metab; 1978 Nov; 47(5):938-43. PubMed ID: 400738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aldosterone synthase inhibition with LCI699: a proof-of-concept study in patients with primary aldosteronism.
    Amar L; Azizi M; Menard J; Peyrard S; Watson C; Plouin PF
    Hypertension; 2010 Nov; 56(5):831-8. PubMed ID: 20837883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of serotonin4 (5-HT4) receptor agonists on aldosterone secretion in idiopathic hyperaldosteronism.
    Lefebvre H; Cartier D; Duparc C; Contesse V; Lihrmann I; Delarue C; Vaudry H; Fischmeister R; Kuhn JM
    Endocr Res; 2000 Nov; 26(4):583-7. PubMed ID: 11196433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary hyperparathyroidism associated with primary hyperaldosteronism.
    Ferriss JB; Brown JJ; Cumming AM; Fraser R; Lever AF; Peacock M; Robertson JI
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):365-70. PubMed ID: 6349207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients.
    Muto S; Sebata K; Watanabe H; Shoji F; Yamamoto Y; Ohashi M; Yamada T; Matsumoto H; Mukouyama T; Yonekura T; Namiki S; Kusano E
    Am J Kidney Dis; 2005 Oct; 46(4):697-705. PubMed ID: 16183425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new diagnostic test for primary aldosteronism.
    Coruzzi P; Musiari L; Biggi A; Carra N; Panzali AF; Novarini A
    Am J Hypertens; 1991 Aug; 4(8):694-9. PubMed ID: 1930852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
    Weinberger MH; Kramer NJ; Grim CE; Petersen LP
    J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucose-induced paradoxical hyperkalemia in patients with suppression of the renin-aldosterone system: prevention by sodium depletion.
    Radó JP
    J Endocrinol Invest; 1979; 2(4):401-6. PubMed ID: 395185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Severe hyperaldosteronism in neonatal Task3 potassium channel knockout mice is associated with activation of the intraadrenal renin-angiotensin system.
    Bandulik S; Tauber P; Penton D; Schweda F; Tegtmeier I; Sterner C; Lalli E; Lesage F; Hartmann M; Barhanin J; Warth R
    Endocrinology; 2013 Aug; 154(8):2712-22. PubMed ID: 23698720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
    Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
    Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
    Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
    J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling.
    Tiu SC; Choi CH; Shek CC; Ng YW; Chan FK; Ng CM; Kong AP
    J Clin Endocrinol Metab; 2005 Jan; 90(1):72-8. PubMed ID: 15483077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism.
    Veglio F; Pinna G; Bisbocci D; Rabbia F; Piras D; Chiandussi L
    J Hum Hypertens; 1990 Oct; 4(5):579-82. PubMed ID: 2283648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.